GE HealthCare Technologies (MEX:GEHC) Moat Score: 7/10 (As of Jul. 01, 2026)


MEX:GEHC GE HealthCare Technologies Inc MEX:GEHC
63 GF Score
Price MXN1,149.89
GF Value MXN1,528.76
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is GE HealthCare Technologies Moat Score?

GE HealthCare Technologies MEX:GEHC +1.82% 63 Moat Score is 7 as of Jul. 01, 2026. GuruFocus rates MEX:GEHC with a GF Score™ of 63/100 and a GF Value™ of MXN1,528.76 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 846 Medical Devices & Instruments companies, GE HealthCare Technologies ranks better than 98.94% on this metric.

GE HealthCare Technologies has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

GE HealthCare Technologies has Wide Moat: GE HealthCare Technologies Inc possesses a wide moat with strong brand strength, valuable intellectual property, and significant regulatory barriers. Its market leadership and durable cost advantages in healthcare technology provide robust competitive advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes GE HealthCare Technologies might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

GE HealthCare Technologies  (MEX:GEHC) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

GE HealthCare Technologies Moat Score Related Terms

MEX:GEHC vs DXCM, STE, ZBH: Moat Score Comparison

For the Medical Devices subindustry, GE HealthCare Technologies's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GE HealthCare Technologies Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Moat Score distribution charts can be found below:

* The bar in red indicates where GE HealthCare Technologies's Moat Score falls into.


MEX:GEHC
63GF Score
GE HealthCare Technologies Inc MEX:GEHC
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
GE HealthCare Technologies (MEX:GEHC) has a Moat Score of 7 as of Jul. 01, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, GE HealthCare Technologies ranks #9 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is GE HealthCare Technologies' Moat Score too high?
GE HealthCare Technologies' current Moat Score is 7. Based on the distribution chart, GE HealthCare Technologies ranks #9 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Moat Score compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #9 out of 846 companies for Moat Score. This places GE HealthCare Technologies in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. GE HealthCare Technologies's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,528.76, compared to a current price of MXN1,149.89 — trading 24.8% below its estimated fair value. The current Moat Score is 7. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current Moat Score is 7 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of MXN1,149.89 is trading 24.8% below its estimated GF Value™ of MXN1,528.76. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for MEX:GEHC:

  • Moat Score: 7
  • GF Value™: MXN1,528.76 vs. price of MXN1,149.89 (24.8% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score

Get the complete analysis for MEX:GEHC

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,149.89
Price
MXN1,528.76
GF Value